These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 23910597)

  • 1. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
    Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
    Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
    Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a novel series of aryl S,N-ketene acetals as antileishmanial agents.
    Suryawanshi SN; Kumar S; Tiwari A; Shivahare R; Chhonker YS; Pandey S; Shakya N; Bhatta RS; Gupta S
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3979-82. PubMed ID: 23673014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
    Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
    Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
    Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
    Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
    Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
    Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
    Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
    Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
    Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
    Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
    Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
    Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
    Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
    Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
    Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of leishmaniasis. Part XII: design, synthesis and bioevaluation of novel triazole integrated phenyl heteroterpenoids as antileishmanial agents.
    Suryawanshi SN; Tiwari A; Kumar S; Shivahare R; Mittal M; Kant P; Gupta S
    Bioorg Med Chem Lett; 2013 May; 23(10):2925-8. PubMed ID: 23582274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
    Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
    Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
    Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
    Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.